CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-02 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2010-02-02 | DAVIE JOSEPH MD PHD Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2010-02-02 | BAYH SUSAN B Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2010-02-02 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2009-09-02 | Keegan Mitchell Vice-President | Grant or award · Qualified stock option (right to buy) | +81,139 | 81,139 | ||
| 2009-09-02 | Keegan Mitchell Vice-President | Grant or award · Non-qualified stock option (right to buy) | +18,861 | 18,861 | ||
| 2009-04-27 | BVF PARTNERS L P/IL 10% owner | Sale | −727,000 | $1.15 | $836K | 8,194,716 |
| 2009-04-27 | BVF PARTNERS L P/IL 10% owner | Sale | −502,000 | $1.15 | $577K | 7,692,716 |
| 2009-04-27 | BVF PARTNERS L P/IL 10% owner | Sale | −1,741,000 | $1.15 | $2.0M | 5,951,716 |
| 2009-02-05 | BAYH SUSAN B Director | Grant or award · Non-qualified stock option (right to buy) | +7,500 | 7,500 | ||
| 2009-02-05 | BAYH SUSAN B Director | Grant or award · Non-qualified stock option (right to buy) | +17,500 | 17,500 | ||
| 2009-02-05 | NOEL MARK Vice-President | Grant or award · Qualified stock option (right to buy) | +59,199 | 59,199 | ||
| 2009-02-05 | NOEL MARK Vice-President | Grant or award · Non-qualified stock option (right to buy) | +15,801 | 15,801 | ||
| 2009-02-05 | DAVIE JOSEPH MD PHD Director | Grant or award · Non-qualified stock option (right to buy) | +7,500 | 7,500 | ||
| 2009-02-05 | DAVIE JOSEPH MD PHD Director | Grant or award · Non-qualified stock option (right to buy) | +17,500 | 17,500 | ||
| 2009-02-05 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +7,500 | 7,500 | ||
| 2009-02-05 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +17,500 | 17,500 | ||
| 2009-02-05 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +7,500 | 7,500 | ||
| 2009-02-05 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +17,500 | 17,500 | ||
| 2009-02-05 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +7,500 | 7,500 |
Page 25 of 29 · 564 trades